Phio Pharmaceuticals Corp. Interest Expense 2011-2026 | PHIO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Phio Pharmaceuticals Corp.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
2 K	6 K	-8 K	-	-	-	-	-	-10 K	6 K	-2 K	9 K	24 K	125 K	2.55 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.55 M	-10 K	270 K

Quarterly Interest Expense Phio Pharmaceuticals Corp.

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6 K	-1 K	7 K	-	-2 K	-2 K	-	-	-1 K	10 K	6 K	-	2 K	-3 K	-3 K	-	53 K	70 K	1 K	-	123 K	955 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
955 K	-3 K	72 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	9.34 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	262 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	9 M	$ 1.61	-2.73 %	$ 189 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Celldex Therapeutics CLDX	927 K	$ 31.72	0.05 %	$ 2.11 B	USA
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
BioNTech SE BNTX	14.2 M	$ 96.94	3.75 %	$ 23.4 B	Germany
Athira Pharma ATHA	1.24 M	-	-	$ 269 M	USA
CRISPR Therapeutics AG CRSP	86.6 M	$ 55.72	-1.17 %	$ 5.01 B	Schweiz
Compugen Ltd. CGEN	281 K	$ 2.69	-3.24 %	$ 251 M	Israel
Galera Therapeutics GRTX	11.4 M	-	-32.59 %	$ 7.61 M	USA
Enlivex Therapeutics Ltd. ENLV	1.93 M	$ 0.82	6.92 %	$ 37.5 M	Israel
Esperion Therapeutics ESPR	3.49 M	$ 3.14	0.16 %	$ 653 M	USA
Eton Pharmaceuticals ETON	1.06 M	$ 30.72	-3.58 %	$ 827 M	USA
Forte Biosciences FBRX	-396 K	$ 19.3	-7.08 %	$ 250 M	USA
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Galectin Therapeutics GALT	2.79 M	$ 2.54	-1.17 %	$ 162 M	USA
IMV IMV	2.34 K	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Cyclacel Pharmaceuticals CYCCP	354 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	2.15 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	6.74 M	-	-	$ 3.37 B	China
Heron Therapeutics HRTX	1.34 M	$ 0.87	-2.33 %	$ 145 M	USA
ImmuCell Corporation ICCC	476 K	$ 10.11	2.12 %	$ 91.3 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	561 K	$ 3.38	-1.46 %	$ 5.56 M	Israel